Updated on 11 October 2013
The Network Verification Challenge also involves Selventa, a personalized healthcare company pioneering the analysis of big data to unravel the complexity of disease. Selventa has played an important role in the development of the biological networks used in this challenge and also developed the software that allows visualization of the models.
“The sbv Improver project is a truly unique initiative which is addressing some of the most fundamental issues facing the scientific community today, including: how can we cope with the explosive growth of data confidently, thoroughly and practically,” said Dr David De Graaf, president and CEO, Selventa.
“By providing high-quality data sets to any scientist who wishes to look at them, openly and for free, and then asking them to scrutinize that data as part of the crowd, we are helping to forge the way towards a more transparent, collaborative and robust framework in which scientific research is conducted,” Added Dr Graaf.